Charles River Nederland BV

Charles River company, provides drug discovery services ranging from target discovery to IND enabling studies. From its facility in Leiden (the Netherlands), Charles River Nederland B.V. offers clients access to cell-based (high throughput) screening in human (primary) cells. In addition, Charles River Nederland B.V. uses target discovery technologies, based on screening proprietary adenoviral shRNA (“SilenceSelect®”) and cDNA (“FlexSelect®”) libraries targeting the drugable human genome and also employing CRISPR/Cas9 technology.